{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:29:17Z","timestamp":1794346157510,"version":"4.9.0"},"reference-count":37,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health (Ricerca Corrente\u2014Linea 1)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>When the Mpox virus (MPXV) began spreading globally in 2022, it became critical to evaluate whether residual immunity from smallpox vaccination provided cross-protection. To assess the cross-immune response to MPXV, we collected serum samples (n = 97) and PBMCs (n = 30) from healthy-donors, either born before 1974 and reporting smallpox vaccination during childhood or born after 1975 and not vaccinated with Vaccinia virus (VACV)-based vaccines. We evaluated the levels of anti-MPXV IgG and neutralizing antibodies (Nabs) and the presence of a T cell response against MPXV. We found anti-MPXV IgG and Nabs in 60 (89.6%) and 40 (70.1%) vaccinated individuals, respectively. We observed a T cell response to Orthopoxviruses and MPXV peptide pools in 30% of vaccinated individuals. We thus show that a high proportion of subjects who received the smallpox vaccine 40 to 60 years ago have humoral cross-immunity, while the T-cell-specific response against MPXV was observed in a smaller group (30%) of vaccinated individuals. This study, combined with information on immunity developed during natural infection or the administration of current vaccines, will contribute to a better understanding of humoral and cellular responses against MPXV.<\/jats:p>","DOI":"10.3390\/vaccines11101541","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:47:30Z","timestamp":1695955650000},"page":"1541","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-4243","authenticated-orcid":false,"given":"Giulia","family":"Matusali","sequence":"first","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Petruccioli","sequence":"additional","affiliation":[{"name":"Translational Research Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2659-0868","authenticated-orcid":false,"given":"Eleonora","family":"Cimini","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology and Farmacology, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0640-8667","authenticated-orcid":false,"given":"Francesca","family":"Colavita","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Bettini","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Tartaglia","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Immunology and Farmacology, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Settimia","family":"Sbarra","sequence":"additional","affiliation":[{"name":"Translational Research Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0924-993X","authenticated-orcid":false,"given":"Silvia","family":"Meschi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Lapa","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-9237","authenticated-orcid":false,"given":"Massimo","family":"Francalancia","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Bordi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0240-7504","authenticated-orcid":false,"given":"Valentina","family":"Mazzotta","sequence":"additional","affiliation":[{"name":"HIV\/AIDS Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Coen","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klizia","family":"Mizzoni","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Beccacece","sequence":"additional","affiliation":[{"name":"Highly Contagious Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5606-8712","authenticated-orcid":false,"given":"Emanuele","family":"Nicastri","sequence":"additional","affiliation":[{"name":"Highly Contagious Infectious Diseases Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pierelli","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa Complessa (UOC) Transfusion Medicine and Stem Cell, San Camillo Forlanini Hospital, 00152 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-4684","authenticated-orcid":false,"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[{"name":"HIV\/AIDS Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-5896","authenticated-orcid":false,"given":"Enrico","family":"Girardi","sequence":"additional","affiliation":[{"name":"Scientific Direction, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Vaia","sequence":"additional","affiliation":[{"name":"General Direction, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-2250","authenticated-orcid":false,"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA"},{"name":"Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2209-5966","authenticated-orcid":false,"given":"Alba","family":"Grifoni","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA"},{"name":"Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8360-4376","authenticated-orcid":false,"given":"Delia","family":"Goletti","sequence":"additional","affiliation":[{"name":"Translational Research Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0291-4490","authenticated-orcid":false,"given":"Vincenzo","family":"Puro","sequence":"additional","affiliation":[{"name":"Risk Management Unit, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7489-5271","authenticated-orcid":false,"given":"Fabrizio","family":"Maggi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases \u201cLazzaro Spallanzani\u201d IRCCS, Via Portuense 292, 00149 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/clinids\/4.5.916","article-title":"Global Eradication of Smallpox","volume":"4","author":"Fenner","year":"1982","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm1273","article-title":"Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox","volume":"11","author":"Hammarlund","year":"2005","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.4049\/jimmunol.172.10.6265","article-title":"Cellular and Humoral Immunity against Vaccinia Virus Infection of Mice","volume":"172","author":"Xu","year":"2004","journal-title":"J. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3390\/v2102381","article-title":"Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections","volume":"2","author":"Xiao","year":"2010","journal-title":"Viruses"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","article-title":"A Prospective Study of Serum Antibody and Protection Against Smallpox","volume":"21","author":"Noble","year":"1972","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: Targets of protective immunity","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1586\/erv.11.46","article-title":"The strategic use of novel smallpox vaccines in the post-eradication world","volume":"10","author":"Golden","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/340517","article-title":"Primary Induction of Human CD8 + Cytotoxic T Lymphocytes and Interferon-\u03b3\u2013Producing T Cells after Smallpox Vaccination","volume":"185","author":"Ennis","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) Disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_10","unstructured":"(2023, April 20). Scientific American. I Was Vaccinated against Smallpox 40 Years Ago. Am I Still Protected?. Available online: https:\/\/www.scientificamerican.com\/article\/i-was-vaccinated-against\/."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/infdis\/jiac409","article-title":"Residual Humoral Immunity Sustained Over Decades in a Cohort of Vaccinia-Vaccinated Individuals","volume":"227","author":"Chan","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.20032083","article-title":"Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-\u03b3\u2013producing T Cell Memory to Smallpox in Humans","volume":"199","author":"Combadiere","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal Study","volume":"121","author":"Taub","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Costantino, V., Trent, M.J., Sullivan, J.S., Kunasekaran, M.P., Gray, R., and MacIntyre, R. (2020). Serological Immunity to Smallpox in New South Wales, Australia. Viruses, 12.","DOI":"10.3390\/v12050554"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1590\/0074-02760150215","article-title":"Evaluating anti-Orthopoxvirus antibodies in individuals from Brazilian rural areas prior to the bovine vaccinia era","volume":"110","author":"Mota","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1023164","DOI":"10.3389\/fimmu.2022.1023164","article-title":"Estimation of anti-orthopoxvirus immunity in Moscow residents and potential risks of spreading Monkeypox virus","volume":"13","author":"Gushchin","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1469-0691.2006.01576.x","article-title":"The persistence of humoral and cellular immunities more than three decades after smallpox vaccination","volume":"13","author":"Kim","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3201\/eid0911.030349","article-title":"Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination","volume":"9","author":"Poccia","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1099\/vir.0.81265-0","article-title":"Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy","volume":"86","author":"Alberini","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e28778","DOI":"10.1002\/jmv.28778","article-title":"Characterization of immune response against monkeypox virus in cohorts of infected patients, historic and newly vaccinated subjects","volume":"95","author":"Sammartino","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine\u2013induced antibodies are necessary and sufficient for protection against monkeypox virus","volume":"11","author":"Golding","year":"2005","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/cit703","article-title":"Human Monkeypox","volume":"58","author":"McCollum","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2444","DOI":"10.1002\/rmv.2444","article-title":"Effect of prior immunisation with smallpox vaccine for protection against human Mpox: A systematic review","volume":"33","author":"Akter","year":"2023","journal-title":"Rev. Med. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(22)00806-4","article-title":"Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: A retrospective cohort study","volume":"23","author":"Fink","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/idr14060083","article-title":"Clinical and Epidemiological Features of Hospitalized and Ambulatory Patients with Human Monkeypox Infection: A Retrospective Observational Study in Portugal","volume":"14","author":"Caria","year":"2022","journal-title":"Infect. Dis. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(22)01436-2","article-title":"Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: A prospective observational cohort study","volume":"400","author":"Alemany","year":"2022","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e28851","DOI":"10.1002\/jmv.28851","article-title":"Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak","volume":"95","author":"Colavita","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.chom.2022.11.003","article-title":"Defining antigen targets to dissect vaccinia virus and monkeypox virus-specific T cell responses in humans","volume":"30","author":"Grifoni","year":"2022","journal-title":"Cell Host Microbe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.chom.2023.04.015","article-title":"Memory profiles distinguish cross-reactive and virus-specific T cell immunity to mpox","volume":"31","author":"Adamo","year":"2023","journal-title":"Cell Host Microbe"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Cohn, H., Bloom, N., Cai, G.Y., Clark, J.J., Tarke, A., Berm\u00fadez-Gonz\u00e1lez, M.C., Altman, D.R., Lugo, L.A., Lobo, F.P., and Marquez, S. (2023). Mpox vaccine and infection-driven human immune signatures: An immunological analysis of an observational study. Lancet Infect. Dis.","DOI":"10.1101\/2023.03.07.23286701"},{"key":"ref_32","first-page":"e37107","article-title":"Global Monkeypox Virus Outbreak 2022: A Bibliometric Analysis","volume":"15","author":"Rehan","year":"2023","journal-title":"Cureus"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e28643","DOI":"10.1002\/jmv.28643","article-title":"Smallpox vaccination-elicited antibodies cross-neutralize 2022-Monkeypox","volume":"95","author":"Criscuolo","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2022","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study\u2014United States, August 19, 2022\u2013March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hazra, A., Zucker, J., Bell, E., Flores, J., Gordon, L., Mitj\u00e0, O., Su\u00f1er, C., Lemaignen, A., Jamard, S., and Nozza, S. (2023). Mpox in people with past infection or a complete vaccination course: A global case series. Lancet Infect. Dis.","DOI":"10.2139\/ssrn.4491622"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/CVI.00148-07","article-title":"Monkeypox-Induced Immunity and Failure of Childhood Smallpox Vaccination to Provide Complete Protection","volume":"14","author":"Karem","year":"2007","journal-title":"Clin. Vaccine Immunol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/10\/1541\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:01:25Z","timestamp":1760130085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/10\/1541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["vaccines11101541"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11101541","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}